European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ... Redox biology 13, 94-162, 2017 | 316 | 2017 |
The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation P Brito, LM Almeida, TCP Dinis Free radical research 36 (6), 621-631, 2002 | 153 | 2002 |
Quantitative biology of hydrogen peroxide signaling F Antunes, PM Brito Redox biology 13, 1-7, 2017 | 141 | 2017 |
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells PM Brito, R Devillard, A Nègre-Salvayre, LM Almeida, TCP Dinis, ... Atherosclerosis 205 (1), 126-134, 2009 | 136 | 2009 |
Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: A role for intracellular glutathione PM Brito, A Mariano, LM Almeida, TCP Dinis Chemico-biological interactions 164 (3), 157-166, 2006 | 79 | 2006 |
Protective effect of diphenyl diselenide against peroxynitrite-mediated endothelial cell death: a comparison with ebselen AF de Bem, B Fiuza, P Calcerrada, PM Brito, G Peluffo, TCP Dinis, ... Nitric oxide 31, 20-30, 2013 | 76 | 2013 |
Neutrophil extracellular traps formation by bacteria causing endometritis in the mare MR Rebordão, C Carneiro, G Alexandre-Pires, P Brito, C Pereira, ... Journal of reproductive immunology 106, 41-49, 2014 | 71 | 2014 |
Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches M Santa-Marta, PM de Brito, A Godinho-Santos, J Goncalves Frontiers in immunology 4, 343, 2013 | 71 | 2013 |
Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells S Rato, S Maia, PM Brito, L Resende, CF Pereira, C Moita, RP Freitas, ... PLoS One 5 (2), e9276, 2010 | 53 | 2010 |
Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2 PM Brito, NF Simoes, LM Almeida, TCP Dinis Apoptosis 13, 1043-1053, 2008 | 40 | 2008 |
Estimation of kinetic parameters related to biochemical interactions between hydrogen peroxide and signal transduction proteins PM Brito, F Antunes Frontiers in Chemistry, 2014 | 29 | 2014 |
Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition J Goncalves, M Santos, R Acurcio, I Iria, L Gouveia, P Matos Brito, ... Alimentary pharmacology & therapeutics 48 (5), 507-522, 2018 | 28 | 2018 |
European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 13: 94–162 J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ... | 11 | 2017 |
Springer Nature: Cham J Galvão, P Brito, FD Santos, F Craveiro, H Almeida, J Vasco, L Neves, ... Switzerland, 2021 | 6 | 2021 |
Methods and cell-based strategies to produce antibody libraries: current state PM de Brito, A Saruga, M Cardoso, J Goncalves Applied Microbiology and Biotechnology, 1-10, 2021 | 3 | 2021 |
Data processing to probe the cellular hydrogen peroxide landscape F Antunes, P Brito Computational Methods for Estimating the Kinetic Parameters of Biological …, 2022 | 2 | 2022 |
Corrigendum to “Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells”[Atherosclerosis 205 (July 2009) 126-134] PM Brito, R Devillard, A Nègre-Salvayre, LM Almeida, TCP Dinis, ... Atherosclerosis 285, 178, 2019 | 1 | 2019 |
MS175 PROTECTIVE EFFECT OF DIPHENYL DISELENIDE AGAINST PEROXYNITRITE-MEDIATED ENDOTHELIAL CELL TOXICITY: A COMPARISON WITH EBSELEN A Bem, P Brito, P Calcerrada, G Pellufo, T Dinis, M Trijillo, JB Rocha, ... Atherosclerosis (Supplements)(Component) 2 (11), 145, 2010 | 1 | 2010 |
Papel do resveratrol no contexto da prevenção da aterosclerose: mecanismos moleculares envolvidos na apoptose e proliferação celular PM de Brito PQDT-Global, 2007 | 1 | 2007 |
Characterization of new HIV diagnoses in the migrant population in a tertiary hospital in Portugal MJ Miguel, J Lourinho, F Goncalves, H Pires, T Nunes, F Vale, L Alves, ... HIV MEDICINE 24, 434-435, 2023 | | 2023 |